Scott Gottlieb Bio | Wiki
Scott Gottlieb is an American physician and investor. He served as the 23rd commissioner of the Food and Drug Administration (FDA) from May 2017 to April 2019. Scott is presently a senior fellow at the conservative think tank the American Enterprise Institute (AEI), and a partner at the venture capital firm New Enterprise Associates (NEA).
He is also a member of the board of directors of drug maker Pfizer, Inc, a member of the board of directors of Illumina, Inc., a contributor to the cable financial news network CNBC, and a frequent guest on the CBS News program Face the Nation.
An elected member of the National Academy of Medicine, Scott is the author of The New York Times best-selling book Uncontrolled Spread on the COVID-19 pandemic and the national security vulnerabilities that it revealed.
Scott Gottlieb Age
Scott was born on June 11, 1972, in East Brunswick, New Jersey, United States. He is 50 years old.
Scott Gottlieb Height
He is a man of average stature and stands at a height of 5 ft 8 in (Approx. .72 m).
Scott Gottlieb Family
He was born and raised in East Brunswick, New Jersey by his parents Stanley and Marsha Gottlieb. Scott’s father is a psychiatrist. He holds an American nationality and belongs to the white ethnicity. He has not share much information about his parents and/or siblings with the public.
Scott Gottlieb Wife
Scott is married to his beautiful wife Allyson Nemeroff. The couple celebrated their wedding in 2004. Together, they share three daughters, the firstborns are twins. They reside in Westport, Connecticut.
Scott Gottlieb Education
He earned his bachelor’s degree in economics from Wesleyan University. After completing his undergraduate education, Scott worked as a healthcare analyst at the investment bank Alex. Brown & Sons in Baltimore. He attended medical school at Icahn School of Medicine at Mount Sinai and completed his residency in internal medicine at the Mount Sinai Hospital.
Scott Gottlieb Delta Variant
On August 20, 2021, Scott urged fellow vaccinated Americans to be on guard about the Covid delta variant, telling CNBC its highly transmissible nature cannot be ignored even by people who have immunity protection.
Scott Gottlieb Pfizer
He was elected as an independent member of the board of directors of Pfizer, Inc. in June 2019. Scott joined the Illumina, Inc. board of directors in February 2020 and the National Resilience, Inc. board of directors in November 2020. He is also a member of the boards of trustees of the Mount Sinai Health System and Wesleyan University.
Scott Gottlieb Fda
Scott worked for the U.S. Food and Drug Administration (FDA) from 2002 to 2003 and 2005 to 2007. He first worked as a senior advisor to the FDA Commissioner and then as the FDA’s Director of Medical Policy Development from 2002 to 2003. Scott helped initiate the FDA’s generic drug user fee program and the Physician Labeling Rule.
He worked on the development of the FDA’s policies related to the tentative approval of fixed-dose combination drugs for the treatment of HIV/AIDS under the PEPFAR program. Scott left the FDA in the spring of 2003 to become a senior advisor to the Administrator of the Centers for Medicare & Medicaid Services (CMS).
He returned to the FDA from 2005 to 2007 as the agency’s Deputy Commissioner for Medical and Scientific Affairs, where he was appointed to the Senior Executive Service and granted a top-secret security clearance.
Scott Gottlieb Face The Nation | CNBC
Scott’s frequent appearances on the CBS Sunday show Face the Nation, as well as CNBC’s Squawk Box, were refreshing in their honesty and sharp analysis. Unlike many in the Covid pundit class, he did not shy away from challenging orthodoxy.
Scott Gottlieb Board Of Directors
In 2015, he served on the Board of Directors of Kure Corp, a provider of vaping products. Scott was elected as an independent member of the board of directors of Pfizer, Inc. in June 2019. He joined the Illumina, Inc. board of directors in February 2020 and the National Resilience, Inc. board of directors in November 2020. Moreover, Scott is also a member of the boards of trustees of the Mount Sinai Health System and Wesleyan University.
Scott Gottlieb New Book
Scott is the author of The New York Times best-selling book Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic which was released on September 21, 2021. The book focuses on the COVID-19 pandemic and the national security vulnerabilities that it revealed.
Uncontrolled Spread debuted at No.5 on The New York Times Best Seller list for Hardcover Nonfiction and at No.6 for Combined Print & E-Book Nonfiction. It also debuted at No.9 on The Wall Street Journal Best Seller list for Hardcover Nonfiction and No.8 on the Publishers Weekly hardcover Nonfiction Best Seller list.
Scott Gottlieb Net Worth
He earns his wealth from his career, therefore, he has amassed a fortune over the years. Scott’s estimated net worth is $1 million.
Who Is Scott Gottlieb
Scott is an American physician and investor. He served as the 23rd commissioner of the Food and Drug Administration (FDA) from May 2017 to April 2019. He is presently a senior fellow at the conservative think tank the American Enterprise Institute (AEI).